These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 7496146)
21. Detection and characterization of Lewis antigens in plasma of Lewis-negative individuals. Evidence of chain extension as a result of reduced fucosyltransferase competition. Henry SM; Oriol R; Samuelsson BE Vox Sang; 1994; 67(4):387-96. PubMed ID: 7701811 [TBL] [Abstract][Full Text] [Related]
22. Immunochemistry of the Lewis blood-group system: isolation and structures of Lewis-c active and related glycosphingolipids from the plasma of blood-group O Le(a-b-) nonsecretors. Hanfland P; Kordowicz M; Peter-Katalinic J; Pfannschmidt G; Crawford RJ; Graham HA; Egge H Arch Biochem Biophys; 1986 May; 246(2):655-72. PubMed ID: 2423032 [TBL] [Abstract][Full Text] [Related]
23. Chemical fingerprinting of glycosphingolipids in meconium of a human blood group O Le(a-b+) secretor. Angström J; Falk KE; Karlsson KA; Larson G Biochim Biophys Acta; 1982 Mar; 710(3):428-36. PubMed ID: 7074123 [TBL] [Abstract][Full Text] [Related]
24. Chromatographic separation of Lewis a and Lewis x oligosaccharides as glycosynthons. Frison N; Meunier L; Marceau P; Quétard C; Strecker G; Roche AC; Mayer R; Monsigny M Biochimie; 2003; 85(1-2):47-51. PubMed ID: 12765774 [TBL] [Abstract][Full Text] [Related]
25. Blood group A glycolipid antigen expression in kidney, ureter, kidney artery, and kidney vein from a blood group A1Le(a-b+) human individual. Evidence for a novel blood group A heptaglycosylceramide based on a type 3 carbohydrate chain. Holgersson J; Clausen H; Hakomori S; Samuelsson BE; Breimer ME J Biol Chem; 1990 Dec; 265(34):20790-8. PubMed ID: 2249988 [TBL] [Abstract][Full Text] [Related]
28. Tissue specificity of glycosphingolipids as expressed in pancreas and small intestine of blood group A and B human individuals. Breimer ME Arch Biochem Biophys; 1984 Jan; 228(1):71-85. PubMed ID: 6198960 [TBL] [Abstract][Full Text] [Related]
29. Biosynthetic pathways for the Leb and Y glycolipids in the gastric carcinoma cell line KATO III as analyzed by a novel assay. Blaszczyk-Thurin M; Sarnesto A; Thurin J; Hindsgaul O; Koprowski H Biochem Biophys Res Commun; 1988 Feb; 151(1):100-8. PubMed ID: 3348768 [TBL] [Abstract][Full Text] [Related]
30. Blood group H antigen with globo-series structure. Isolation and characterization from human blood group O erythrocytes. Kannagi R; Levery SB; Hakomori S FEBS Lett; 1984 Oct; 175(2):397-401. PubMed ID: 6479351 [TBL] [Abstract][Full Text] [Related]
31. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor. Teneberg S; Lönnroth I; Torres López JF; Galili U; Halvarsson MO; Angström J; Karlsson KA Glycobiology; 1996 Sep; 6(6):599-609. PubMed ID: 8922955 [TBL] [Abstract][Full Text] [Related]
32. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors. Skovlund VR APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838 [TBL] [Abstract][Full Text] [Related]
33. Characterization of blood-group-ABO(H)-active glycosphingolipids in type-AB human erythrocytes. Kushi Y; Tsunoda A; Komatsuzaki A; Watanabe K; Kasama T; Handa S Eur J Biochem; 1995 Aug; 231(3):862-7. PubMed ID: 7649187 [TBL] [Abstract][Full Text] [Related]
34. Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization. Clausen H; Levery SB; Kannagi R; Hakomori S J Biol Chem; 1986 Jan; 261(3):1380-7. PubMed ID: 3944091 [TBL] [Abstract][Full Text] [Related]
35. Chemical and immunological identification of glycolipid-based blood group ABH and Lewis antigens in human kidney. Breimer ME; Karlsson KA Biochim Biophys Acta; 1983 Jan; 755(2):170-7. PubMed ID: 6830844 [TBL] [Abstract][Full Text] [Related]
36. Non-acid glycosphingolipid expression in plasma of an A1 Le(a-b+) secretor human individual: identification of an ALeb heptaglycosylceramide as major blood group component. Lindström K; Breimer ME; Jovall PA; Lanne B; Pimlott W; Samuelsson BE J Biochem; 1992 Mar; 111(3):337-45. PubMed ID: 1587795 [TBL] [Abstract][Full Text] [Related]
37. Isolation of H and Leb active human salivary mucins and structures of their sugar chains with the H and Ley (Y) determinants. Nadano D; Mukoyama H Nihon Hoigaku Zasshi; 1990 Aug; 44(4):259-66. PubMed ID: 1702480 [TBL] [Abstract][Full Text] [Related]
38. Blood group type glycosphingolipids of human kidneys. Structural characterization of extended globo-series compounds. Holgersson J; Jovall PA; Samuelsson BE; Breimer ME Glycoconj J; 1991 Oct; 8(5):424-33. PubMed ID: 1841684 [TBL] [Abstract][Full Text] [Related]
39. Investigation of Lewis phenotypes in Polynesians: evidence of a weak secretor phenotype. Henry SM; Benny AG; Woodfield DG Vox Sang; 1990; 58(1):61-6. PubMed ID: 2316213 [TBL] [Abstract][Full Text] [Related]
40. Expression of mucin peptide and blood group ABH- and Lewis-related carbohydrate antigens in normal human conjunctiva. Garcher C; Bara J; Bron A; Oriol R Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1184-91. PubMed ID: 7510273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]